network
theori
autoimmun
present
recent
experiment
data
relev
understand
pathogenesi
aid
schemat
effector
cell
specif
selfantigen
exist
normal
activ
modul
prevent
network
regulatori
cell
result
mimicri
molecular
compon
microorgan
selfantigen
autoimmun
diseas
trigger
specif
foreign
pathogen
alter
state
activ
network
suppress
activ
convers
procedur
known
tcell
vaccin
autolog
effector
cell
reinject
vitro
stimul
attenu
may
alter
state
network
activ
suppress
numer
observ
review
support
concept
autoimmun
activ
destruct
noninfect
cell
activ
presum
trigger
antigen
viral
origin
like
one
envelop
protein
base
hypothesi
tcell
vaccin
procedur
effector
cell
respons
autoimmunopath
activ
hivseroposit
patient
propos
similar
one
known
experiment
studi
autoimmun
present
test
human
autoimmun
diseas
purpos
would
prevent
tcell
loss
onset
immunodefici
diseas
hivseroposit
patient
apart
potenti
therapeut
valu
procedur
use
therapeut
test
insight
gain
immunopathogenesi
aid
previou
commun
atlan
atlan
et
al
suggest
tcell
vaccin
may
appliedto
hivseroposit
patient
order
prevent
develop
aid
tcell
vaccin
welldocu
procedur
design
specif
cellular
im
submit
decemb
accept
februari
correspond
sent
present
address
servic
de
biophysiqu
hbpital
de
ihdtel
dieu
place
du
parvi
de
notr
dame
pari
franc
munotherapi
autoimmun
cohen
tcell
vaccin
effect
number
experiment
autoimmun
diseas
present
test
human
affect
multipl
sclerosi
hafler
et
al
zhang
et
al
rheumatoid
arthriti
van
laar
et
al
toxic
effect
encourag
preliminari
result
sever
line
evid
suggest
develop
acquir
immunodefici
syndrom
aid
individu
infect
human
immunodefici
viru
hiv
result
sole
direct
cytopath
effect
viru
shearer
ziegler
stite
klatzmann
montagni
klatzmann
gluckman
procaccia
et
al
ascher
sheppard
isaksson
et
al
kaplan
et
al
kopelman
zollapazn
schattner
martineza
et
al
bacchetti
moss
duesberg
schnittman
et
al
ascher
sheppard
hoffman
et
al
maddox
hsia
spector
morrow
ec
al
true
sensit
pcr
techniqu
shown
proport
lymphocyt
latent
infect
hiv
much
higher
origin
thought
even
clinic
latenc
period
embretson
et
al
howev
presenc
viral
dna
genom
cell
lethal
absenc
activ
therefor
question
remain
open
concern
immunopatholog
aid
long
variabl
interv
infect
hiv
develop
immunodefici
diseas
klatzmann
gluckman
isaksson
et
al
kaplan
et
al
bachetti
moss
clinic
patholog
similar
known
autoimmun
disord
procaccia
et
al
kopelman
zollapazn
eat
experiment
autoimmun
thyroid
aa
adjuv
arthriti
aid
acquir
immun
defici
syndrom
cellmedi
immun
cmv
cytomegaloviru
cll
cytotox
lymphocyt
dth
delayedtyp
hypersensit
eae
autoimmun
encephalomyel
schattner
morrow
et
al
observ
genet
correl
pattern
hiv
diseas
progress
steel
et
al
jeannet
et
al
simmond
et
al
puppo
et
al
louie
et
al
suggest
complex
patholog
process
involv
immun
respons
organ
hiv
infect
number
immunopath
mechan
sever
featur
autoimmun
propos
contribut
develop
aid
includ
crossreact
recognit
selfmhc
secondari
antiidiotyp
respons
found
first
larg
set
refer
mention
elimin
infect
cell
virusspecif
hlarestrict
cytotox
lymphocyt
shearer
zinkernagel
elimin
uninfect
cell
immun
respons
direct
hiv
klatzmann
gluckman
salk
lyerli
et
al
lanzavecchia
et
al
lanzavecchia
siliciano
et
al
israelbiet
et
al
morrow
et
al
andor
cell
antigen
stricker
et
al
martineza
et
al
kowalski
et
al
zarl
et
al
unrestrict
tcell
activ
hivinfect
macrophag
consequ
immun
dysregul
tcell
death
sheppard
superantigen
effect
hiv
compon
lead
widespread
delet
clone
imberti
et
al
nonspecif
immunosuppress
effect
mediat
hiv
compon
includ
weinhold
et
al
tat
gene
product
viscidi
et
al
inappropri
activationinduc
tcell
death
apoptosi
matur
cell
process
normal
observ
immatur
thymocyt
ameisen
capron
terai
et
al
montagni
et
al
groux
et
al
versushost
hostversusgraft
respons
allogen
class
ii
mhc
antigen
consequ
immun
suppress
also
suggest
shearer
klatzmann
gluckman
moser
et
al
basi
observ
crossreact
mhc
hiv
protein
suggest
hiv
envelop
antigen
induc
chronic
autoreact
similar
graftversushost
diseas
habeshaw
et
al
recent
highli
plausibl
hypothesi
immunopatholog
develop
arcaid
propos
pantaleo
et
al
hypothesi
base
observ
larg
number
human
immunodefici
virus
hivinfect
cell
present
lymphoid
organ
clinic
latenc
period
associ
progress
dysrupt
follicular
dendrit
cell
fdc
network
lymph
node
suggest
progress
diseas
hivinfect
cell
longer
prevent
circul
peripher
blood
destroy
lymph
node
fdc
network
continu
perform
normal
function
trap
antigen
present
activ
larg
number
circul
infect
cell
would
allow
viral
replic
cell
death
respons
increas
viraemia
observ
late
stage
diseas
howev
critic
event
mechan
name
destruct
fdc
seem
produc
direct
viral
cytopath
effect
immunopath
respons
lead
activ
cytotox
lymphocyt
ctl
infiltr
lymph
node
follicl
thu
one
hand
immun
respons
hiv
infect
might
immunoprotect
destruct
hivinfect
cell
neutral
free
viru
hand
howev
aspect
immun
respons
might
autoimmunopath
contribut
develop
immunodefici
destruct
infect
uninfect
cell
andor
follicular
dendrit
cell
lymph
node
rate
tccell
declin
hiv
diseas
progress
might
thu
reflect
part
balanc
immunoprotect
autoimmunopath
facet
antihiv
immun
respons
present
articl
first
section
review
relev
experiment
theoret
background
autoimmun
tcell
vaccin
recent
develop
network
theori
autoimmun
cohen
cohen
atlan
atlan
hoffersnyd
cohen
young
atlan
cohen
cohen
cohen
shed
light
natur
variou
autoimmunopath
mechan
might
oper
hiv
diseas
suggest
way
autoimmunopath
process
might
prevent
control
accord
theori
exampl
molecular
mimicri
strong
foreign
epitop
selfantigen
may
lead
break
toler
selfantigen
perturb
preexist
regulatori
network
autoimmunopath
destruct
cell
might
thu
result
case
destabil
selftolerancemaintain
regulatori
network
immun
respons
hiv
compon
homolog
antigen
normal
present
cell
anoth
altern
would
hiv
antigen
present
cell
follicular
dendrit
cell
would
similar
destabil
effect
activ
helper
cytotox
cell
cell
section
ii
shall
examin
exist
evid
autoimmunopath
hiv
diseas
discuss
concept
develop
section
appli
possibl
immunotherapi
hivseroposit
patient
sever
model
regulatori
network
might
relat
autoimmunopath
hiv
diseas
implic
respect
potenti
mode
intervent
discuss
section
iii
shall
propos
detail
protocol
first
therapeut
test
implement
gener
discuss
serv
conclus
network
theori
autoimmun
contrari
global
theori
idiotyp
network
initi
pioneer
work
jern
network
theori
autoimmun
local
descript
interact
identifi
cell
popul
involv
occurr
specif
autoimmun
diseas
cohen
cohen
accord
main
concept
autoimmun
natur
horton
present
healthi
organ
control
network
regulatori
cell
possibl
lymphokin
b
cell
antibodi
prevent
normal
exist
effector
cell
reactiv
given
selfantigen
activ
balanc
stimul
suppress
effect
depend
connect
structur
network
ie
natur
strength
interact
network
element
depend
structur
network
stabil
normal
patholog
state
effector
cell
directli
respons
diseas
activ
inactiv
respect
howev
connect
element
modifi
extern
antigen
stimuli
intern
regulatori
signal
produc
network
tempor
evolut
atlan
hoffersnyd
thu
network
like
neural
network
central
nervou
system
endow
cognit
properti
ie
selforgan
learn
adapt
capac
atlan
cohen
cohen
cohen
relev
exampl
mechan
discuss
section
ii
part
b
network
theori
autoimmun
base
evid
effector
cell
specif
selfantigen
normal
exist
vivo
guilbert
et
al
burn
et
al
cohen
young
effector
cell
either
prevent
exert
autoimmun
effect
depend
state
activ
regulatori
cell
popul
mainli
sole
antigenspecif
idiotypicspecif
bennun
et
al
holoshitz
et
al
lider
et
al
lider
et
al
kakimoto
et
al
lohs
et
al
roubati
et
al
fine
tune
regulatori
system
appropri
perturb
introduct
foreign
antigen
crossreact
given
selfantigen
interf
antigen
present
ensu
stimuli
deliv
variou
compon
cell
network
chang
steadi
state
network
way
express
rather
suppress
autoimmun
occur
convers
regulatori
network
enhanc
strengthen
respect
abil
suppress
autoimmun
exposur
nonpathogen
form
relev
effector
cell
enhanc
learn
memor
structur
network
subsequ
exposur
either
pathogen
effector
cell
potenti
immunopathogeni
antigen
would
produc
autoimmun
concept
particularli
relev
studi
tcell
vaccin
prophylact
therapeut
procedur
autoimmun
diseas
bennun
et
al
cohen
et
al
cohen
cohen
c
atlan
hoffersnyd
roubati
et
al
cohen
young
elia
et
al
beraud
atlan
cohen
hafler
et
al
studi
experiment
autoimmun
diseas
provid
data
underli
network
theori
autoimmun
best
studi
model
experiment
autoimmun
encephalomyel
eae
diseas
character
acut
onset
paralysi
genet
suscept
anim
follow
appropri
induct
stimuli
shown
mediat
effector
cell
specif
myelin
basic
protein
mbp
b
spontan
recoveri
may
occur
associ
appear
suppressor
cell
react
specif
idiotyp
determin
present
antimbp
cell
bennun
cohen
ellerman
et
al
antigen
determin
mbp
lb
observ
lider
et
al
lohs
et
al
led
formul
model
onset
remiss
relaps
eae
autoimmun
diseas
explain
chang
interact
among
effector
cell
two
pair
regulatori
element
antigenspecif
helper
suppressor
cell
ii
idiotypespecif
helper
suppressor
cell
cohen
atlan
accord
model
state
autoimmun
result
chang
normal
balanc
among
variou
element
regulatori
network
previous
serv
suppress
antiself
respons
autoimmun
state
may
stabl
persist
even
agent
precipit
chang
longer
present
altern
host
respons
foreign
antigen
induc
de
nova
format
regulatori
network
lead
autoimmun
continu
presenc
crossreact
selfepitop
may
perpetu
autoimmunopath
state
network
even
precipit
antigen
clear
experiment
model
autoimmun
diseas
suggest
exist
level
complex
regul
autoimmun
exampl
adjuv
arthriti
aa
autoimmun
diseas
may
experiment
induc
inject
kill
mycobacferium
tuberculosi
contain
antigen
protein
crossreact
joint
cartilag
proteoglycan
diseas
may
also
induc
inocul
cell
antim
tuberculosi
clone
also
recogn
proteoglycan
van
eden
et
al
recent
investig
natur
dynam
regulatori
network
aa
suggest
least
one
addit
compon
may
involv
karin
atlan
cohen
onset
sever
autoimmun
diseas
trigger
tuberculosi
correl
presenc
popul
nonspecif
suppressor
cell
downregul
antiidiotyp
regulatori
cell
greater
extent
cytolyt
effector
cell
accord
propos
network
model
atlan
cohen
result
net
increas
effector
activ
contrasuppress
pathogen
respons
partial
nonspecif
lohs
et
al
karin
direct
specif
antiidiotyp
regulatori
cell
also
anticlonotyp
regulatori
cell
latter
includ
cell
control
respons
differ
epitop
selfantigen
other
involv
regul
unrel
autoimmun
diseas
eae
thu
conceiv
partial
nonspecif
suppressor
cell
might
exert
contrasuppress
effect
facilit
express
autoimmunopath
respons
diseas
regard
interest
note
subpopul
suppressor
cell
act
via
releas
solubl
inhibitori
factor
observ
associ
hiv
infect
joli
et
al
sadatsowti
et
al
pathogenesi
experiment
autoimmun
thyroid
eat
provid
anoth
exampl
addit
network
complex
disord
produc
experiment
inocul
cell
thyroglobulinspecif
cytotox
tcell
clone
may
entail
dysfunct
immun
regulatori
network
contain
humor
well
cellular
compon
roubati
et
al
regard
given
homolog
describ
hiv
envelop
glycoprotein
immunoglobulin
bjork
possibl
antihiv
respons
crossreact
selfimmunoglobulin
might
nonspecif
perturb
humor
arm
bipartit
cellularhumor
regulatori
system
therebi
contribut
immunopathogenesi
aid
although
detail
mechan
network
regul
autoimmun
may
complic
present
understood
appreci
dynam
aspect
regulatori
network
use
consid
mean
perturb
system
intent
strengthen
restor
develop
nonimmunopath
state
network
model
suggest
vaccin
autoimmun
effector
cell
form
condit
cell
capabl
exert
pathogen
effect
elicit
antiidiotyp
regulatori
cell
might
suppress
autoimmun
effector
cell
respons
therebi
prevent
amelior
autoimmun
diseas
exampl
model
shown
figur
network
effector
cell
five
popul
regulatori
cell
account
complic
paradox
data
aa
atlan
cohen
exampl
particularli
relev
sinc
involv
particip
foreign
pathogen
tuberculosi
work
adjuv
trigger
autoimmun
framework
propos
hypothesi
aid
role
hiv
could
similar
detail
h
atlan
et
al
atlan
cohen
full
dot
arrow
repres
activ
suppress
connect
respect
higher
dose
tuberculosi
mt
foreign
pathogen
work
adjuv
onset
aa
probabl
mimicri
selfantigen
produc
sever
form
diseas
tcell
vaccin
attenu
effector
cell
prevent
onset
diseas
experiment
observ
state
activ
differ
cell
popul
differ
condit
healthi
diseas
vaccin
account
steadi
state
network
comput
function
connect
tcell
vaccin
work
learn
process
network
follow
given
law
modifi
connect
way
exposur
pathogen
dose
mt
produc
diseas
state
cohen
atlan
atlan
hoffersnyd
atlan
cohen
concept
consist
result
studi
use
tcell
vaccin
number
experiment
autoimmun
diseas
vaccin
subpathogen
dose
effector
cell
larg
number
effect
attenu
irradi
treatment
glutaraldehyd
mitomycin
c
hydrostat
pressur
agent
cohen
cohen
lider
et
al
shown
elicit
antiidiotyp
lider
et
al
lider
et
al
roubati
et
al
elia
et
al
andor
antiergotyp
lohs
et
al
beraud
suppressor
cell
effect
prevent
andor
treat
eae
bennun
et
al
lider
et
al
lohs
et
al
aa
holoshitz
et
al
lider
et
al
eat
roubati
et
al
l
collageniiinduc
arthriti
kakimoto
et
al
spontan
autoimmun
diabet
elia
et
al
experiment
autoimmun
uveiti
beraud
human
clinic
trial
initi
explor
use
tcell
vaccin
treatment
autoimmun
diseas
evid
toxic
hafler
et
al
zhang
et
al
van
laar
et
al
patient
treat
multipl
sclerosi
still
earli
make
assess
possibl
clinic
improv
slow
evolut
diseas
howev
expect
abovement
previou
anim
studi
eae
lider
et
al
lohs
et
al
antiidiotyp
respons
observ
tcell
vaccin
myelin
basic
proteinspecif
tcell
clone
zhang
et
al
similar
procedur
achiev
differ
group
van
laar
et
al
patient
suffer
rheumatoid
arthriti
variabl
diseas
durat
averag
slight
decreas
diseas
activ
observ
indic
clearer
improv
patient
recent
onset
diseas
view
forego
first
question
ask
concern
given
autoimmunopath
mechan
natur
selfantigen
involv
given
selfantigen
must
identifi
target
autolog
ctl
andor
autoantibodi
vaccin
procedur
aim
strengthen
defici
regulatori
respons
capabl
suppress
activ
ctl
antibodi
previous
suggest
immunosuppress
observ
aid
might
part
attribut
hivtrigg
immunopath
respons
direct
uninfect
well
infect
cell
kiatzmann
montagni
klatzmann
gluckman
salk
lyerli
et
al
lanzavecchia
et
al
siliciano
et
al
lanzavecchia
israelbiet
et
al
case
antigen
must
look
membran
cell
howev
mention
anoth
altern
would
consid
lymph
node
fdc
target
ctl
activ
hiv
infect
view
exist
experiment
evid
shall
consid
implic
two
possibl
target
autoimmunopath
respons
cell
fdc
far
identif
antigen
regulatori
network
concern
autoimmun
viewpoint
simplest
assumpt
would
molecul
selfantigen
howev
viral
molecul
interact
must
involv
trigger
immunopath
cell
therefor
hypothesi
cell
target
immunopath
respons
must
divid
two
possibl
model
support
data
literatur
review
first
model
viral
antigen
like
envelop
glycoprotein
directli
involv
play
role
self
antigen
incorpor
tcell
membran
second
model
true
selfantigen
preexist
membran
activ
hiv
infect
antigen
model
accord
view
autoimmunopath
destruct
may
occur
result
effect
kill
infect
cell
express
among
viral
antigen
membran
uninfect
cell
bound
free
fig
bind
like
occur
support
high
degre
shed
infecti
virus
releas
gelderblom
et
al
schneider
et
al
detect
sera
hivseroposit
individu
oh
et
al
free
bound
molecul
might
well
intern
depend
upon
rout
metabol
reexpress
associ
class
make
target
classic
cytotox
cell
class
ii
mhc
molecul
hoffenbach
et
al
detect
mhcrestrict
antienv
cytotox
lymphocyt
seroposit
seroneg
donor
sinc
frequenc
cell
declin
seroposit
clinic
deterior
author
hypothes
respons
primarili
immunoprotect
howev
also
note
envspecif
cytotox
cell
might
capabl
caus
autoimmunopath
destruct
mediat
bound
env
molecular
mimicri
siliciano
et
al
abl
precis
demonstr
potenti
autoimmunopath
effect
detect
cytotox
lymphocyt
normal
seroneg
individu
could
kill
antigenspecif
mhcrestrict
manner
uninfect
activ
autolog
cell
puls
presenc
cytotox
cell
suffici
frequenc
would
expect
accord
network
theori
induc
format
network
would
regul
activ
effector
cell
given
persist
hiv
infect
therefor
continu
presenc
hiv
antigen
postul
regulatori
network
establish
would
configur
favour
stimul
respons
viewpoint
autoimmun
howev
network
would
ineffect
insofar
would
fail
restrain
effect
autoimmunopath
destruct
thu
model
autoimmunopath
aid
would
result
bound
uninfect
cell
coupl
ii
regulatori
network
configur
stimul
rather
suppress
autoimmun
effect
signific
autoimmunopath
would
depend
upon
rel
balanc
protect
aspect
respons
destruct
infect
cell
consequ
reduct
viral
prolifer
immunopath
aspect
respons
destruct
normal
cell
consequ
reduct
residu
immunolog
potenti
b
membran
selfantigen
model
second
model
close
analog
classic
experiment
autoimmun
disord
sever
find
suggest
one
selfantigen
might
normal
present
cell
membran
preexist
suppress
ctl
antigen
would
activ
hiv
infect
exampl
zarl
et
al
found
ctl
blood
hivseroposit
patient
hivinfect
chimpanze
capabl
kill
uninfect
cell
hivseroposit
patient
seroneg
control
israelbiet
et
al
found
cell
hivinfect
patient
abl
kill
allogen
ebvtransform
b
cell
cell
blast
seroposit
seroneg
subject
hoffenbach
et
al
plata
observ
unusu
high
frequenc
ctl
precursor
prime
hiv
antigen
virus
repertoir
normal
human
absenc
hiv
infect
instanc
autoimmun
trigger
foreign
pathogen
van
eden
et
al
morrow
et
al
karin
cohen
young
horton
trigger
true
autoimmun
respons
hiv
antigen
could
impli
mimicri
antigen
preexist
selfantigen
class
ii
mhc
antigen
suggest
postul
selfantigen
hoffman
et
al
howev
case
one
might
expect
aid
character
signific
deplet
b
cell
antigenpres
cell
primari
expressor
mhc
class
ii
antigen
rather
addit
deplet
rather
one
might
hypothes
cell
carri
addit
uniqu
marker
crossreact
perhap
structur
physiolog
associ
cell
membran
either
directli
complex
mhc
molecul
detect
hoffenbach
et
al
siliciano
et
al
antienv
specif
cytotox
lymphocyt
seroneg
individu
might
postul
due
exist
crossreact
selfantigen
inabl
siliciano
et
al
detect
kill
cell
uninfect
autolog
cell
puls
might
relat
subthreshold
level
surfac
express
selfantigen
marker
ambient
condit
assay
summari
accord
membran
selfantigen
model
fig
effect
specif
put
crossreact
selfantigen
exist
prior
hiv
infect
inact
owe
domin
suppress
effect
exert
preexist
regulatori
network
phenomenon
would
similar
eg
observ
experiment
aa
van
eden
et
al
atlan
cohen
foreign
bacteri
antigen
adjuv
tuberculosi
crossreact
joint
cartilag
selfantigen
bacteri
antigen
serv
strong
antigen
stimulu
preexist
regulatori
network
quantit
relat
amount
inject
absenc
adjuv
stimul
network
normal
suppress
state
prevent
activ
cytotox
effector
cell
joint
cartilag
similarli
tqcell
selfantigen
model
preexist
regulatori
network
would
destabil
strong
antigen
stimul
produc
introduct
foreign
result
network
would
driven
new
steadi
state
character
activ
effector
cell
abl
destroy
viva
uninfect
markerbear
cell
independ
presenc
bound
reexpress
earli
cours
hiv
infect
activ
cytotox
cell
still
subject
network
regul
suppressor
cell
therefor
mild
form
autoimmun
diseas
typifi
moder
degre
kill
cell
occur
time
howev
network
move
patholog
state
suppressor
cell
activ
suppress
insuffici
instanc
patholog
autoimmun
progress
diseas
may
explain
sever
mechan
exampl
onset
activ
state
antigen
progress
increas
effici
diversif
antigen
present
may
produc
reinforc
antigen
stimulu
process
alter
selfantigen
present
lead
eg
display
previous
cryptic
selfdetermin
lehmann
et
al
may
explain
time
cours
autoimmun
diseas
includ
virusinduc
progress
state
autoimmun
chronic
activ
hepat
ohtani
et
al
eaelik
lesion
induc
coronaviru
watanab
et
al
viciou
circl
cytokinedriven
upregul
autoantigen
present
lehmann
et
al
may
produc
crossreact
viral
antigen
may
also
occur
absenc
crossreact
lead
ongo
tcell
stimul
tcell
recruit
determin
spread
greater
cytokin
product
forth
process
acceler
intercurr
infecti
noninfecti
stress
contribut
increas
viru
viral
antigen
product
lead
heighten
activ
effector
helper
regulatori
cell
particular
intercurr
infect
could
also
precipit
increas
contrasuppress
aa
level
contrasuppressor
activ
vari
directli
dose
adjuv
mycobacterium
administ
karin
atlan
cohen
mechan
could
contribut
observ
certain
opportunist
infect
appear
acceler
clinic
progress
hivaid
case
mention
far
connect
structur
regulatori
network
concern
kind
viciou
circl
would
amount
reinforc
mechan
learn
distribut
memori
wellknown
neural
network
model
weisbuch
atlan
hoffersnyd
atlan
cohen
result
earlier
diseasefre
state
network
destabil
network
evolv
toward
activ
pathogen
state
c
common
featur
two
model
tcell
vaccin
ctl
therapeu
tic
test
model
section
la
lb
humor
particip
onset
hivtrigg
autoimmunopath
respons
possibl
eat
might
mediat
exampl
report
homolog
epitop
immunoglobulin
bjork
well
cell
surfac
protein
role
bind
beretta
et
al
gold
et
al
young
might
result
perturb
possibl
tcellbcel
regulatori
network
case
search
anticlonotyp
cell
popul
activ
increas
concentr
differ
antibodi
cytokin
respons
cell
clone
line
use
vaccin
procedur
provid
use
inform
natur
antigen
regulatori
network
differ
reinforc
mechan
discuss
lb
may
also
oper
model
section
la
sinc
mention
trigger
first
immunopath
respons
induc
even
absenc
crossreact
preexist
selfdetermin
viral
antigen
increas
effici
gp
antigen
present
specif
bind
direct
process
cell
report
lanzavecchia
et
al
lanzavecchia
et
al
author
found
cell
captur
solubl
present
mhc
classiirestrict
clone
wellestablish
autoimmun
disord
associ
hla
haplotyp
diseas
incid
report
develop
arcaid
steel
et
al
jeannet
et
al
simmond
et
al
puppo
et
al
louie
et
al
associ
would
consist
either
model
develop
autoimmunopath
diseas
consequ
hiv
infect
howev
instanc
autoimmun
trigger
facilit
foreign
pathogen
observ
similar
syndrom
cellular
lesion
occur
absenc
viral
infect
idiopath
tlymphocytopenia
immunodefici
without
viru
fauci
smith
et
al
ho
et
al
small
number
patient
genet
predisposit
would
strongli
favour
second
model
theori
two
model
although
mutual
exclus
differ
significantli
prospect
cure
therapeut
elimin
viru
first
case
complet
elimin
viru
would
also
remov
sourc
simul
selfantigen
ie
bound
cell
autoimmun
destruct
cell
would
abrog
second
case
howev
remov
incit
crossreact
foreign
antigen
would
necessarili
result
return
immunoregulatori
network
predominantli
suppress
mode
new
steadi
state
autoimmun
might
stabl
state
sustain
continu
presenc
bona
fide
tcspecif
selfantigen
practic
term
howev
possibl
complet
erad
establish
hiv
infect
unlik
least
forseeabl
futur
therefor
regardless
model
may
prove
correct
would
use
explor
adjunct
intervent
aim
specif
control
autoimmunopath
destruct
cell
either
case
tcell
vaccin
use
autolog
clone
cytotox
cell
would
expect
enhanc
induc
antiidiotyp
regulatori
cell
network
would
act
downregul
activ
cytotox
cell
occur
whether
viral
infect
concurr
control
elimin
focu
intervent
autoimmunopath
destruct
occur
result
host
respons
infect
rather
virocytopath
destruct
occur
result
infect
per
se
associ
reduct
viral
burden
independ
mean
howev
would
expect
synerg
limit
autoimmunopath
destruct
reduc
antigen
stimul
autoimmunopath
effector
cell
extent
autoimmunopath
destruct
cell
major
factor
develop
hivassoci
diseas
tcell
vaccin
serv
enabl
hivinfect
host
live
integr
compens
perturb
induc
persist
viral
infect
condit
hiv
infect
might
expect
come
resembl
infect
persist
virus
ebv
cmv
hsv
rel
innocu
case
addit
respons
propos
intervent
possibl
test
valid
hypothesi
expand
exampl
look
vivo
activ
suppressor
cell
tcr
specif
consid
abovement
observ
progress
destruct
fdc
follicular
dendrit
cell
cytotox
cell
latenc
period
pantaleo
et
al
still
face
tissular
antiself
immun
respons
question
rais
natur
antigen
transform
fdc
target
ctl
view
observ
concomit
accumul
virus
lymph
node
reason
assum
ctl
might
activ
larg
number
viral
antigen
present
fdc
addit
antigen
present
function
fdc
microenviron
lymphoid
organ
may
favor
onset
viciou
circl
reinforc
antigen
present
atlan
hoffersnyd
atlan
cohen
lehmann
et
al
wherebi
strength
activ
variou
antigen
determin
increas
continu
discuss
howev
contrari
tccell
target
model
direct
document
experiment
indic
possibl
specif
mechan
respons
activ
ctl
fdc
therefor
sinc
want
produc
overal
suppress
antivir
cellular
respons
antifdc
cytotox
cell
first
character
antigen
specif
tcell
vaccin
procedur
cell
test
meantim
propos
procedur
describ
follow
section
might
also
turn
effect
context
fdc
target
model
would
case
extent
ctl
might
particip
immunopath
respons
involv
fdc
well
direct
destruct
cell
discuss
section
iil
view
forego
consider
propos
tcell
vaccin
explor
first
strategi
reduc
direct
autoimmunopath
tccell
destruct
hiv
infect
tcell
vaccin
techniqu
cohen
would
consist
reinject
clone
autolog
effector
cytotox
cell
vitro
activ
either
irradi
treatment
crosslink
agent
glutaraldehyd
prevent
prolifer
thu
although
effector
cell
present
regulatori
network
immunolog
activ
form
autolog
nonprolif
henc
pathogen
reinject
cell
intend
launch
network
new
stabl
state
regulatori
suppressor
cell
strongli
activ
result
chang
connect
network
would
suppress
develop
activ
pathogen
effector
helper
cell
therebi
suppress
autoimmunopath
key
success
approach
identif
respons
effector
cell
discuss
earlier
work
hypothesi
cytotox
effect
specif
respons
immunopath
destruct
uninfect
cell
culmin
aid
howev
still
possibl
autoimmunopath
destruct
cell
could
mediat
cytotox
effect
specif
direct
hiv
antigen
cellular
antigen
crossreact
hiv
antigen
cellular
antigen
crossreact
hiv
eg
new
epitop
expos
result
bind
stricker
et
al
kowalski
et
al
effect
tcell
vaccin
cytotox
effect
assess
look
desir
induc
modif
regulatori
network
form
vivo
activ
suppressor
cell
antibodi
qualit
quantit
assess
respons
determin
whether
use
pursu
studi
use
effect
specif
flow
chart
present
tabl
outlin
first
protocol
current
develop
propos
studi
initi
small
group
hiv
seroposit
compar
viral
burden
recent
begun
manifest
declin
cell
facilit
subsequ
analysi
prefer
studi
subject
follow
serial
count
least
month
whose
level
studi
entri
demonstr
significantli
neg
slope
thu
possibl
therapeut
effect
could
subsequ
assess
look
slowdown
slope
cellmedi
immun
respons
assess
standard
skin
test
delayedtyp
hypersensit
dth
sinc
correl
observ
favour
clinic
histori
hivseroposit
patient
high
dth
respons
postvaccin
followup
might
indic
dth
respons
could
use
criterion
futur
patient
select
peripher
blood
lymphocyt
plate
limit
dilut
irradi
autolog
antigenpres
cell
clone
perform
outset
permit
calcul
tabl
effect
vaccin
therapeut
efficaci
plan
prepar
autolog
ebvtransform
b
cell
introduc
gene
would
provid
perman
sourc
stimul
target
cell
ctl
gener
test
well
growth
expans
antigen
also
test
sinc
ctl
could
also
activ
interact
molecul
differ
precursor
frequenc
prior
therapeut
intervent
respond
hivuninfect
clone
expand
vitro
test
antigen
specif
cytotox
mhc
restrict
phenotyp
suggest
tcell
receptor
tcr
gene
usag
also
explor
sinc
use
restrict
number
vp
gene
might
permit
futur
develop
nonautolog
therefor
gener
applic
prepar
cohen
techniqu
use
success
instanc
experiment
autoimmun
howel
et
al
vandenbark
et
al
offner
et
al
eae
owhashi
et
al
eat
texier
et
al
monoclon
antibodi
tcr
antigenspecif
effector
tcell
produc
protect
effect
similar
induc
vaccin
effector
cell
moreov
eae
tcr
specif
encephalitogen
determin
mbp
use
similar
va
v
chain
two
differ
speci
although
c
antigen
determin
differ
burn
el
al
similarli
case
character
conserv
tcr
structur
could
dispens
techniqu
need
cumbersom
autolog
prepar
patient
per
patient
basi
initi
howev
autolog
antigenspecif
cytotox
clone
expand
activ
vitro
follow
irradi
treatment
crosslink
agent
prior
reinocul
donor
anticip
effect
vaccin
may
evalu
serial
measur
dth
respons
ii
amlr
autolog
mix
lymphocyt
reaction
inject
tcell
clone
iii
level
circul
cell
idiotyp
specif
ident
inject
cell
iv
level
antiidiotyp
antiergotyp
tcell
respons
hand
measur
therapeut
efficaci
would
monitor
follow
peripher
blood
cell
count
absolut
percent
total
cell
clinic
indic
diseas
progress
measur
static
viru
burden
hivdna
pcr
activ
viru
burden
glycinedissoci
antigen
hivrna
pcr
might
includ
monitor
secondari
effect
viru
clearanc
major
thrust
aid
research
identif
respons
viru
elucid
biolog
hope
discov
mean
viru
might
success
control
elimin
underli
rational
viru
hiv
directli
caus
diseas
syndrom
known
aid
therefor
strategi
vaccin
base
product
neutral
antivir
antibodi
howev
sever
line
evid
indic
antivir
antibodi
product
could
counterproduct
favour
viral
infect
prevent
effici
cellmedi
immun
suspicion
base
known
antagon
humor
cellular
respons
observ
mimicri
hiv
protein
immunoglobulin
well
selfepitop
compon
immun
system
beretta
el
al
gold
et
al
young
bjork
may
enabl
viru
escap
strong
hostimmun
respons
sastri
arlinghau
altern
strategi
propos
develop
antihiv
vaccin
would
elicit
strong
cellmedi
immun
cmi
virusspecif
ctl
absenc
neutral
antibodi
product
sastri
arlinghau
shearer
clerici
salk
et
al
howev
discuss
earlier
becom
appar
sever
aspect
hiv
infect
difficult
reconcil
notion
viru
sole
direct
proxim
caus
diseas
moreov
viral
stimul
ctl
activ
much
succeed
complet
erad
viral
infect
may
maintain
divert
factor
autoimmun
direct
cell
infect
noninfect
well
fdc
lymphoid
organ
word
autoimmunopath
disord
precipit
hiv
infect
may
import
proxim
caus
hivrel
diseas
therefor
parallel
vaccin
strategi
aim
develop
earli
prevent
chronic
hiv
infect
convers
seroposit
therapeuticprophylact
strategi
autoimmunopath
disord
necessari
hivinfect
seroposit
patient
thesi
present
major
caus
develop
hivrel
diseas
destruct
cell
cytotox
lymphocyt
experiment
test
thesi
propos
cytotox
lymphocyt
detect
seroposit
seroneg
individu
postul
kill
via
surfac
uninfect
well
infect
cell
also
perhap
via
tcspecif
selfantigen
crossreact
discuss
within
context
network
theori
becom
testabl
hypothesi
sinc
tcell
vaccin
autolog
cytotox
lymphocyt
expect
specif
abrog
activ
immunopath
effector
cell
success
approach
depend
upon
rel
import
immunoprotect
compar
autoimmunopath
effect
effector
cell
upon
exist
immunoprotect
factor
specif
hiv
antigen
addit
direct
cytotox
ctl
cell
certainli
possibl
autoimmunopath
effect
could
trigger
hiv
infect
discuss
introduct
section
ii
one
might
consid
fdc
rather
addit
cell
could
target
autoimmun
mechan
trigger
hiv
infect
word
cytotox
cell
activ
fdc
would
trigger
hiv
antigen
would
respons
observ
destruct
lymph
node
reticulum
lead
increas
viraemia
tccell
loss
put
antifdcspecif
effector
cell
could
identifi
seroposit
patient
expand
vitro
tcell
vaccin
procedur
cell
could
design
attempt
case
signific
consequ
view
aid
manner
shift
focu
emphasi
hiv
alon
hiv
context
particular
immun
system
introduc
discoveri
new
fact
observ
render
inadequ
classic
clonal
select
concept
simpl
causeandeffect
relationship
exposur
foreign
antigen
product
specif
antibodi
antigen
rather
mere
system
defenc
foreign
invad
immun
system
appear
today
complex
dynam
network
interact
element
effector
cell
antigenpres
cell
variou
regulatori
cell
modul
genet
factor
cytokin
mutual
recognit
unit
particular
recent
studi
autoimmun
see
eg
addit
mention
pereira
et
al
coutinho
bandeira
cohen
shown
immun
respons
molecular
cellular
level
normal
trigger
selfconstitu
selfantigen
mhc
molecul
idiotyp
etc
least
much
molecul
cell
come
outer
world
thu
discuss
elsewher
atlan
cohen
problem
complex
gener
divers
selforgan
enter
field
immunolog
immun
system
emerg
evolv
comput
network
selforgan
entiti
nonprogram
histori
encount
partial
random
intern
extern
antigen
stimuli
constantli
integr
serv
modul
specifi
gener
initi
genet
determin
shift
emphasi
mean
one
must
focu
complex
interact
hiv
incom
stimulu
immun
system
preexist
function
network
similar
nervou
neuroendocrin
system
constant
process
selforgan
wherea
reduct
viral
burden
appropri
combin
chemotherapi
activ
immun
passiv
administr
hyperimmun
globulin
may
use
pursu
measur
may
suffici
autoimmunopath
compon
diseas
may
need
address
independ
end
goal
therapeut
intervent
would
help
immun
system
reorgan
retain
regain
function
state
capabl
need
coexist
indefinit
persist
viral
infect
goal
reminisc
use
bcg
vaccin
tuberculosi
preantibiot
era
draw
accumul
insight
better
understood
autoimmun
disord
propos
tcell
vaccin
investig
hivinfect
individu
mean
strengthen
host
immun
regulatori
network
consequ
control
autoimmunopath
specif
implement
advantag
requir
detail
understand
mechan
order
effect
sinc
emerg
natur
histori
hivaid
consid
light
autoimmun
disord
precipit
microorgan
fact
result
applic
may
possibl
learn
dynam
human
immun
system
expos
hiv
indepth
understand
dynam
coupl
precis
identif
specif
autoimmunopath
effector
tcell
clone
assess
tcr
variabl
gene
usag
contribut
much
develop
effect
therapeut
potenti
prophylact
vaccin
hivrel
diseas
discuss
tcell
receptor
vaccin
would
easili
broadli
vaccin
basi
applic
autolog
tcell
implement
patientbypati
par
un
antigen
dorigin
viral
le
plu
probabl
mai
non
le
seul
ant
la
protein
denvelopp
sur
la
base
de
cett
hypothes
le
auteur
propos
dappliqu
une
procedur
de
vaccin
par
cellul
contr
de
celhrl
effectric
respons
dune
activit
autoimmun
pathologiqu
chez
de
sujet
seropositif
pour
le
vih
cett
procedur
est
semblabl
cell
mise
au
point
chez
ianim
sur
de
modtl
experimentaux
dautoimmunitt
actuel
teste
chez
lhomm
sur
de
maladi
autoimmun
le
recherch
est
dempkher
la
destruct
de
cellul
et
linstal
de
defici
immunitair
chez
de
sujet
seropositif
pour
le
vih
mai
en
dehor
de
son
efficacit
cventuel
cett
procedur
present
lavantag
dun
test
therapeutiqu
doh
lon
est
en
droit
dattendr
de
nouvel
inform
sur
la
pathologi
immunitair
du
sida
matscl
sida
autoimmunitt
lymphocyt
immunotherapi
reseaux
vaccin
par
cellul
immunopathogenes
revu
